These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 30867224)

  • 61. Neurofilament light chain: a biomarker for genetic frontotemporal dementia.
    Meeter LH; Dopper EG; Jiskoot LC; Sanchez-Valle R; Graff C; Benussi L; Ghidoni R; Pijnenburg YA; Borroni B; Galimberti D; Laforce RJ; Masellis M; Vandenberghe R; Ber IL; Otto M; van Minkelen R; Papma JM; Rombouts SA; Balasa M; Öijerstedt L; Jelic V; Dick KM; Cash DM; Harding SR; Jorge Cardoso M; Ourselin S; Rossor MN; Padovani A; Scarpini E; Fenoglio C; Tartaglia MC; Lamari F; Barro C; Kuhle J; Rohrer JD; Teunissen CE; van Swieten JC
    Ann Clin Transl Neurol; 2016 Aug; 3(8):623-36. PubMed ID: 27606344
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic Approach to Atypical Parkinsonian Syndromes.
    McFarland NR
    Continuum (Minneap Minn); 2016 Aug; 22(4 Movement Disorders):1117-42. PubMed ID: 27495201
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ELISA in the multiplex era: potentials and pitfalls.
    Tighe PJ; Ryder RR; Todd I; Fairclough LC
    Proteomics Clin Appl; 2015 Apr; 9(3-4):406-22. PubMed ID: 25644123
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
    Magdalinou NK; Paterson RW; Schott JM; Fox NC; Mummery C; Blennow K; Bhatia K; Morris HR; Giunti P; Warner TT; de Silva R; Lees AJ; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1240-7. PubMed ID: 25589779
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.
    Respondek G; Stamelou M; Kurz C; Ferguson LW; Rajput A; Chiu WZ; van Swieten JC; Troakes C; Al Sarraj S; Gelpi E; Gaig C; Tolosa E; Oertel WH; Giese A; Roeber S; Arzberger T; Wagenpfeil S; Höglinger GU;
    Mov Disord; 2014 Dec; 29(14):1758-66. PubMed ID: 25370486
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability.
    Assarsson E; Lundberg M; Holmquist G; Björkesten J; Thorsen SB; Ekman D; Eriksson A; Rennel Dickens E; Ohlsson S; Edfeldt G; Andersson AC; Lindstedt P; Stenvang J; Gullberg M; Fredriksson S
    PLoS One; 2014; 9(4):e95192. PubMed ID: 24755770
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings.
    Seppälä TT; Nerg O; Koivisto AM; Rummukainen J; Puli L; Zetterberg H; Pyykkö OT; Helisalmi S; Alafuzoff I; Hiltunen M; Jääskeläinen JE; Rinne J; Soininen H; Leinonen V; Herukka SK
    Neurology; 2012 May; 78(20):1568-75. PubMed ID: 22517093
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder.
    Borroni B; Premi E; Agosti C; Alberici A; Cerini C; Archetti S; Lanari A; Paghera B; Lucchini S; Caimi L; Padovani A
    J Neurol Neurosurg Psychiatry; 2011 Aug; 82(8):834-8. PubMed ID: 21345847
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain.
    De Strooper B; Annaert W; Cupers P; Saftig P; Craessaerts K; Mumm JS; Schroeter EH; Schrijvers V; Wolfe MS; Ray WJ; Goate A; Kopan R
    Nature; 1999 Apr; 398(6727):518-22. PubMed ID: 10206645
    [TBL] [Abstract][Full Text] [Related]  

  • 71. More powerful procedures for multiple significance testing.
    Hochberg Y; Benjamini Y
    Stat Med; 1990 Jul; 9(7):811-8. PubMed ID: 2218183
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
    Jabbari E; Woodside J; Guo T; Magdalinou NK; Chelban V; Athauda D; Lees AJ; Foltynie T; Houlden H; Church A; Hu MT; Rowe JB; Zetterberg H; Morris HR
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):768-773. PubMed ID: 30867224
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transcranial sonography for the discrimination of idiopathic Parkinson's disease from the atypical parkinsonian syndromes.
    Bouwmans AE; Vlaar AM; Srulijes K; Mess WH; Weber WE
    Int Rev Neurobiol; 2010; 90():121-46. PubMed ID: 20692498
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions.
    Magdalinou N; Lees AJ; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1065-75. PubMed ID: 24691581
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders.
    Constantinescu R; Zetterberg H; Holmberg B; Rosengren L
    Parkinsonism Relat Disord; 2009 Mar; 15(3):205-12. PubMed ID: 18562238
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differentiation of atypical Parkinson syndromes.
    Höglinger GU; Kassubek J; Csoti I; Ehret R; Herbst H; Wellach I; Winkler J; Jost WH
    J Neural Transm (Vienna); 2017 Aug; 124(8):997-1004. PubMed ID: 28243754
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cerebrospinal fluid alpha-synuclein as a biomarker for Parkinson's disease diagnosis: a systematic review and meta-analysis.
    Gao L; Tang H; Nie K; Wang L; Zhao J; Gan R; Huang J; Zhu R; Feng S; Duan Z; Zhang Y; Wang L
    Int J Neurosci; 2015; 125(9):645-54. PubMed ID: 25202803
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Saeed U; Lang AE; Masellis M
    Front Neurol; 2020; 11():572976. PubMed ID: 33178113
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Atypical parkinsonian syndromes: a general neurologist's perspective.
    Deutschländer AB; Ross OA; Dickson DW; Wszolek ZK
    Eur J Neurol; 2018 Jan; 25(1):41-58. PubMed ID: 28803444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.